Laura Goodall posted in clinical trials • ebola • glaxosmithkline • GSK • trials • vaccine on October 20th, 2014.
The pharmaceuticals company GlaxoSmithKline (GSK) has said that its potential Ebola vaccine isn’t likely to be ready until late 2015. GSK is one of several companies trying to fast-track a vaccine to prevent the spread of Ebola in West Africa, compressing trials that would normally take up to 10 years into just 12 months. According to GSK’s press […]
Continue reading “GSK Ebola vaccine won’t be ready until late 2015 – experts respond”